Sector revisions AtriCure, Inc.

Stocks

Market Closed - Nasdaq Other stock markets 16:00:00 2026-07-24 EDT			5-day change	1st Jan Change
35.04 ^USD	+6.18%		+0.26%	-11.43%

07-23	AtriCure, Inc., Q2 2026 Earnings Call, Jul 23, 2026
07-23	AtriCure Q2 Swings to Adjusted Earnings, Revenue Rises	MT

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. Revenue rev.	4m. EPS revision	4m. Revenue rev.	1y. EPS revision	1y. Revenue rev.	Visibility	Nbr of analysts
	ATRICURE, INC.							8
	ABBOTT LABORATORIES							24
	MEDTRONIC PLC							25
	CENCORA, INC.							12
	HOYA CORPORATION							15
	BECTON, DICKINSON AND COMPANY							11
	MEDLINE INC.							26
	DEXCOM, INC.							25
	WEST PHARMACEUTICAL SERVICES, INC.							15
	STERIS PLC							7
	TERUMO CORPORATION							13
	SARTORIUS STEDIM BIOTECH							14
	ZIMMER BIOMET HOLDINGS, INC.							20
	SOLVENTUM CORPORATION							13
	FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED							11
	ALIGN TECHNOLOGY, INC.							14
	BAXTER INTERNATIONAL INC.							11
	INSULET CORPORATION							23
	GLOBUS MEDICAL, INC.							12
	DEMANT A/S							20
	Average							16
	Weighted average by Cap.							19